Complete response to imatinib mesylate treatment in a 12-month-old patient with chronic myeloid leukemia.
作者信息
Arancibia Alejandro Mauricio, Bendit Israel, Epelman Sidnei
出版信息
Pediatr Blood Cancer. 2008 May;50(5):1078. doi: 10.1002/pbc.21439.
PMID:18085674
Abstract
摘要
相似文献
1
Complete response to imatinib mesylate treatment in a 12-month-old patient with chronic myeloid leukemia.
Pediatr Blood Cancer. 2008 May;50(5):1078. doi: 10.1002/pbc.21439.
2
[Monitoring bcr/abl mRNA levels in imatinib mesylate treated chronic myeloid leukemia patients by real-time quantitative RT-PCR].
Zhonghua Xue Ye Xue Za Zhi. 2005 Jan;26(1):1-5.
3
Molecular responses in patients with chronic myelogenous leukemia in chronic phase treated with imatinib mesylate.
Clin Cancer Res. 2005 May 1;11(9):3425-32. doi: 10.1158/1078-0432.CCR-04-2139.
4
Prolonged treatment with imatinib mesylate in patients with advanced chronic myeloid leukemia causes a reduction of bcr/abl mRNA levels independent of cytogenetic response.
Ann Hematol. 2003 Jun;82(6):333-5. doi: 10.1007/s00277-003-0660-y. Epub 2003 May 7.
5
Chronic myeloid leukemia with an e13a3 BCR-ABL fusion: benign course responsive to imatinib with an RT-PCR advisory.
Am J Hematol. 2004 Feb;75(2):92-5. doi: 10.1002/ajh.10456.
6
Response to imatinib in a patient with chronic myeloid leukemia simultaneously expressing p190(BCR-ABL) oncoprotein and JAK2V617F mutation.
Leuk Res. 2010 Jan;34(1):e27-9. doi: 10.1016/j.leukres.2009.08.009. Epub 2009 Sep 12.
7
Outcome of four patients with chronic myeloid leukemia after imatinib mesylate discontinuation.
Haematologica. 2005 Jul;90(7):979-81.
8
Hematological and molecular response evaluation of CML patients on imatinib.
J Assoc Physicians India. 2007 Feb;55:109-13.
9
Complete cytogenetic and molecular response after imatinib treatment for chronic myeloid leukemia in a patient with atypical karyotype and BCR-ABL b2a3 transcript.
Cancer Genet Cytogenet. 2007 Apr 15;174(2):111-5. doi: 10.1016/j.cancergencyto.2006.11.021.
10
Complete molecular remission in chronic myelogenous leukemia after imatinib therapy.
N Engl J Med. 2002 Aug 15;347(7):539-40. doi: 10.1056/NEJM200208153470719.
Zotero 插件